OAC
RCEL icon

OMERS Administration Corp’s Avita Medical RCEL Stock Holding History

OMERS Administration Corp’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-21,000
Closed -$107K – 1277
2025
Q3 		$107K Buy
+21,000
New +$110K ﹤0.01% 1044

Other funds holding RCEL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

OMERS Administration Corp's RCEL Position: Q4 2025 in Review

OMERS Administration Corp sold out of Avita Medical (RCEL) in Q4 2025, closing a stake of 21,000 shares — an estimated $107K sold.

OMERS Administration Corp first reported a position in RCEL in Q3 2025 and held it in 1 quarter. The position peaked at $107K in Q3 2025. 67 funds tracked by Wall St. Rank hold RCEL as of Q4 2025.

  • OMERS Administration Corp reported no remaining Avita Medical position as of Q4 2025 after selling out during the quarter.
  • OMERS Administration Corp sold 21,000 Avita Medical shares in Q4 2025, an estimated $107K.
  • OMERS Administration Corp first reported a position in Avita Medical in Q3 2025 and held it in 1 quarter.
  • OMERS Administration Corp's Avita Medical position peaked at $107K in Q3 2025.
  • 67 funds tracked by Wall St. Rank held Avita Medical as of Q4 2025.

Based on OMERS Administration Corp's 13F filing for Q4 2025, filed 13 Feb 2026.